Ainex Corporation
PrivateLast Round
Series C
May 28, 2026
Total Funding Raised
$6.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ainex Corporation operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in May 2026.
Ainex Corporation is a medical artificial intelligence company that develops and distributes AI-based gastrointestinal endoscopy diagnostic assistance software.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ainex Corporation Comparables
Compare Ainex Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Waycen Inc. | 93% | |
| AI Medical Service Inc. | 87% | |
| Wuhan ENDOANGEL Medical Technology Co., Ltd. | 83% |
For institutional investors. Book with your work email.
Ainex Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 28, 2026 | ||||
| Grant | Mar 27, 2026 | ||||
| Series B | Dec 31, 2024 | ||||
| Grant | Jul 16, 2024 |
For institutional investors. Book with your work email.
Ainex Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kingo Investment Partners | Series C |
| UON Investment | Series C |
| Daekyo Investment | Series C |
| Government of South Korea | Grant |
| SW Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 182% MoM, reaching 3.4K.
- May 28, 2026
Raised $7M from Daekyo Investment, UON Investment, SW Investment, and Kingo Investment Partners.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientAug 4, 2026
Ainex Corp. agrees to supply its independently developed ENAD platform to National University Hospital, a leading public tertiary hospital in Singapore, after evaluation against competing global solutions.
For institutional investors. Book with your work email.
Ainex Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ainex Corporation's valuation, stock price, and market status.
Is Ainex Corporation a public or private company?
Ainex Corporation is a private company.
What is the current stock price of Ainex Corporation?
Ainex Corporation is a private company, so its shares have no public market price. Caplight tracks Ainex Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ainex Corporation worth (valuation)?
Valuation information for Ainex Corporation is not publicly available.
Can I buy Ainex Corporation stock?
Ainex Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ainex Corporation's last funding round?
Ainex Corporation's most recent funding round was Series C on May 28, 2026.
Who are the main investors in Ainex Corporation?
Key investors in Ainex Corporation include Kingo Investment Partners, UON Investment, Daekyo Investment, Government of South Korea, SW Investment.
Will Ainex Corporation IPO soon?
No public IPO plans have been announced for Ainex Corporation.
How can I track Ainex Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Ainex Corporation's shares on secondary markets.